Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RETA | AMGN | GILD | CELG | ILMN |
Company | Reata Pharma | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 172.34 | 273.45 | 67.47 | 108.01 | 121.97 |
High | 172.46 | 274.35 | 67.90 | 108.59 | 122.04 |
Low | 172.32 | 267.24 | 65.26 | 107.27 | 116.91 |
Last | 172.36 | 269.78 | 65.36 | 108.24 | 120.78 |
Change | +0.04 | -3.23 | -1.72 | +0.11 | -2.09 |
% Change | +0.02% | -1.18% | -2.56% | +0.10% | -1.70% |
Volume | 1,988,500 | 907,697 | 7,789,487 | 191,230,496 | 607,000 |
20-Day Average Volume | 810,510 | 2,103,078 | 6,482,464 | 16,188,930 | 1,497,159 |
Previous Close | 172.32 | 273.01 | 67.08 | 108.13 | 122.87 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | No | Yes |
Technicals | |||||
20-Day Moving Average | 170.84 | 270.72 | 68.69 | 108.17 | 125.60 |
20-Day Raw Stochastic | 97.36% | 32.71% | 0.93% | 63.25% | 19.31% |
20-Day Relative Strength | 81.56% | 45.17% | 28.48% | 64.69% | 41.53% |
Weighted Alpha | +177.60 | +9.35 | -23.62 | +46.30 | -38.98 |
Today's Opinion | 100% Buy | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
Previous Opinion | 100% Buy | 40% Sell | 100% Sell | 100% Buy | 88% Sell |
Last Month's Opinion | 100% Buy | 24% Buy | 88% Sell | 100% Buy | 24% Sell |
Performance | |||||
5-Days | |||||
%Chg | +0.18% since 09/18/23 | +2.68% since 04/18/24 | -1.24% since 04/18/24 | -1.97% since 11/13/19 | +3.21% since 04/18/24 |
Low | 171.96 on 09/19/23 | 260.68 on 04/19/24 | 65.26 on 04/25/24 | 107.27 on 11/20/19 | 116.61 on 04/19/24 |
High | 172.46 on 09/25/23 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
1-Month | |||||
%Chg | +1.99% since 08/25/23 | -3.92% since 03/25/24 | -9.98% since 03/25/24 | +5.14% since 10/18/19 | -10.17% since 03/25/24 |
Low | 168.67 on 09/05/23 | 260.68 on 04/19/24 | 65.26 on 04/25/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
High | 172.46 on 09/25/23 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
3-Month | |||||
%Chg | +83.77% since 06/23/23 | -13.04% since 01/25/24 | -18.56% since 01/25/24 | +13.63% since 08/20/19 | -15.64% since 01/25/24 |
Low | 88.80 on 06/27/23 | 260.68 on 04/19/24 | 65.26 on 04/25/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
High | 172.46 on 09/25/23 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
6-Month | |||||
%Chg | +101.14% since 03/24/23 | -0.87% since 10/25/23 | -16.65% since 10/25/23 | +14.14% since 05/20/19 | +5.71% since 10/25/23 |
Low | 76.54 on 05/10/23 | 249.70 on 10/31/23 | 65.26 on 04/25/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
High | 172.46 on 09/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
Key Statistics | |||||
Market Capitalization, $K | 6,575,535 | 146,436,016 | 83,519,768 | 77,035,920 | 19,567,662 |
Shares Outstanding, K | 38,150 | 536,376 | 1,245,077 | 711,714 | 159,255 |
Annual Sales | 2,220,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
Annual Net Income | -311,900,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
Last Quarter Sales | 22,750,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
Last Quarter Net Income | 193,000,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
60-Month Beta | 1.42 | 0.58 | 0.19 | 1.41 | 1.19 |
Per-Share Information | |||||
Most Recent Earnings | -2.32 on 08/08/23 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
Latest Earnings Date | 11/14/23 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 143.06 |